DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,755 filers reported holding DANAHER CORPORATION in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,152,764 | +3.0% | 8,677 | -0.3% | 0.24% | +6.8% |
Q2 2023 | $2,089,680 | -1.5% | 8,707 | +3.5% | 0.22% | -1.3% |
Q1 2023 | $2,121,169 | -6.9% | 8,416 | -1.9% | 0.22% | -15.5% |
Q4 2022 | $2,277,834 | +1.8% | 8,582 | -0.9% | 0.26% | -7.3% |
Q3 2022 | $2,237,000 | -0.2% | 8,659 | -2.0% | 0.29% | +6.7% |
Q2 2022 | $2,241,000 | -8.3% | 8,839 | +6.1% | 0.27% | -1.8% |
Q1 2022 | $2,445,000 | -5.5% | 8,334 | +6.0% | 0.27% | -7.5% |
Q4 2021 | $2,586,000 | +14.6% | 7,860 | +6.0% | 0.30% | +4.6% |
Q3 2021 | $2,257,000 | +18.7% | 7,413 | +4.6% | 0.28% | +12.4% |
Q2 2021 | $1,902,000 | +20.2% | 7,088 | +0.8% | 0.25% | +10.1% |
Q1 2021 | $1,582,000 | +2.7% | 7,029 | +1.3% | 0.23% | -4.2% |
Q4 2020 | $1,541,000 | +22.1% | 6,936 | +18.4% | 0.24% | +7.2% |
Q3 2020 | $1,262,000 | +26.2% | 5,860 | +3.6% | 0.22% | +19.4% |
Q2 2020 | $1,000,000 | +26.6% | 5,655 | -0.9% | 0.19% | +8.1% |
Q1 2020 | $790,000 | -9.1% | 5,707 | +0.8% | 0.17% | +9.6% |
Q4 2019 | $869,000 | +55.7% | 5,664 | +46.5% | 0.16% | +48.1% |
Q3 2019 | $558,000 | 0.0% | 3,865 | -1.0% | 0.11% | -15.2% |
Q2 2019 | $558,000 | – | 3,903 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |